The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE(−/−)FXR(−/−) Mice

BACKGROUND: Farnesoid X receptor (FXR), a bile acid–activated nuclear receptor, is a potent regulator of glucose and lipid metabolism as well as of bile acid metabolism. Previous studies have demonstrated that FXR deficiency is associated with metabolic derangements, including atherosclerosis and no...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yenna, Kim, Bo-Rahm, Kang, Geun-Hyung, Lee, Gwan Jae, Park, Young Joo, Kim, Haeryoung, Jang, Hak Chul, Choi, Sung Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743579/
https://www.ncbi.nlm.nih.gov/pubmed/34986301
http://dx.doi.org/10.3803/EnM.2021.1100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743579/
https://www.ncbi.nlm.nih.gov/pubmed/34986301
http://dx.doi.org/10.3803/EnM.2021.1100

Ejemplares similares